Disposition of 1200 shares by Scott Gawel of Intel at 24.46 subject to Rule 16b-3
| 285512AF6 | 62.90 4.68 6.93% |
About 62% of 285512AF6's investor base is looking to short. The analysis of the overall prospects from investing in EA 295 15 FEB 51 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 285512AF6's historical and current headlines, can help investors time the market. In addition, many technical investors use EA 295 15 bond news signals to limit their universe of possible portfolio assets.
285512AF6 |
Filed transaction by Intel Officer: Cvp, Chief Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at fnarena.com
 |
EA 295 15 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 285512AF6 bond to make a market-neutral strategy. Peer analysis of 285512AF6 could also be used in its relative valuation, which is a method of valuing 285512AF6 by comparing valuation metrics with similar companies.
Peers
285512AF6 Related Equities
| KLTR | Kaltura | 0.43 | ||||
| INKT | Mink Therapeutics | 0.30 | ||||
| REGN | Regeneron Pharmaceuticals | 1.21 | ||||
| KSPI | Joint Stock | 1.32 | ||||
| MNMD | Mind Medicine | 1.92 | ||||
| ARDX | Ardelyx | 7.87 |
Other Information on Investing in 285512AF6 Bond
285512AF6 financial ratios help investors to determine whether 285512AF6 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 285512AF6 with respect to the benefits of owning 285512AF6 security.